Eagle Boston Investment Management Inc. increased its stake in shares of Albemarle Co. (NYSE:ALB) by 4.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,422 shares of the specialty chemicals company’s stock after purchasing an additional 521 shares during the quarter. Eagle Boston Investment Management Inc.’s holdings in Albemarle were worth $1,833,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp boosted its stake in Albemarle by 258.1% in the third quarter. Bank of New York Mellon Corp now owns 4,561,987 shares of the specialty chemicals company’s stock valued at $621,845,000 after acquiring an additional 3,287,989 shares during the last quarter. Jennison Associates LLC boosted its stake in Albemarle by 21.4% in the third quarter. Jennison Associates LLC now owns 7,797,076 shares of the specialty chemicals company’s stock valued at $1,062,819,000 after acquiring an additional 1,375,546 shares during the last quarter. Janus Henderson Group PLC boosted its stake in Albemarle by 907.7% in the second quarter. Janus Henderson Group PLC now owns 817,035 shares of the specialty chemicals company’s stock valued at $86,230,000 after acquiring an additional 735,956 shares during the last quarter. Artisan Partners Limited Partnership boosted its stake in Albemarle by 6,185.5% in the second quarter. Artisan Partners Limited Partnership now owns 731,690 shares of the specialty chemicals company’s stock valued at $77,223,000 after acquiring an additional 720,049 shares during the last quarter. Finally, TIAA CREF Investment Management LLC boosted its stake in Albemarle by 69.2% in the second quarter. TIAA CREF Investment Management LLC now owns 1,661,821 shares of the specialty chemicals company’s stock valued at $175,389,000 after acquiring an additional 679,453 shares during the last quarter. 87.10% of the stock is currently owned by institutional investors and hedge funds.

Shares of Albemarle Co. (NYSE ALB) opened at $137.06 on Monday. The company has a quick ratio of 1.56, a current ratio of 2.11 and a debt-to-equity ratio of 0.35. The firm has a market cap of $15,144.58, a price-to-earnings ratio of 33.93, a price-to-earnings-growth ratio of 2.07 and a beta of 1.72. Albemarle Co. has a twelve month low of $83.10 and a twelve month high of $144.99.

Albemarle (NYSE:ALB) last posted its earnings results on Wednesday, November 8th. The specialty chemicals company reported $1.08 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.07 by $0.01. The company had revenue of $755.00 million for the quarter, compared to analyst estimates of $732.19 million. Albemarle had a net margin of 30.07% and a return on equity of 11.61%. The business’s revenue for the quarter was up 15.4% compared to the same quarter last year. During the same period last year, the business posted $0.91 earnings per share. sell-side analysts anticipate that Albemarle Co. will post 4.47 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, January 2nd. Shareholders of record on Friday, December 15th will be issued a $0.32 dividend. The ex-dividend date is Thursday, December 14th. This represents a $1.28 annualized dividend and a yield of 0.93%. Albemarle’s dividend payout ratio (DPR) is presently 16.56%.

A number of brokerages have issued reports on ALB. CIBC began coverage on shares of Albemarle in a research note on Thursday, August 17th. They issued an “outperform” rating and a $133.00 price objective on the stock. Jefferies Group LLC reaffirmed a “buy” rating on shares of Albemarle in a research note on Tuesday, October 24th. SunTrust Banks, Inc. cut shares of Albemarle from a “buy” rating to a “hold” rating and set a $121.00 price objective on the stock. in a research note on Wednesday, August 9th. Royal Bank Of Canada raised their price objective on shares of Albemarle from $149.00 to $155.00 and gave the company an “outperform” rating in a research note on Friday, November 10th. Finally, BidaskClub cut shares of Albemarle from a “buy” rating to a “hold” rating in a research note on Saturday, August 12th. Nine analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $128.45.

ILLEGAL ACTIVITY WARNING: “Albemarle Co. (ALB) Shares Bought by Eagle Boston Investment Management Inc.” was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another website, it was stolen and republished in violation of United States & international copyright & trademark legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/albemarle-co-alb-shares-bought-by-eagle-boston-investment-management-inc/1728611.html.

Albemarle Company Profile

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.